بسم هللا الرحمن الرحيم POLIOMYELITIS AFP Surveillance Gamal Eldin Mohamed Osman WHO.POLIO PROGRAMME. SAAN`A, YEMEN The poliovirus … Leon Lansingh Brunhilde Poliomyelitis Outcome of Poliovirus Infection Paralytic poliomyelitis (0.1 – 1%) Non-paralytic poliomyelitis (10 %) Abortive poliomyelitis (4 – 5%) Unapparent or sub-clinical infection (90 – 95%) Guillain-Barré syndrome: is an acute inflammatory demyelinating polyneuropathy characterized by progressive muscle weakness and areflexia Any age Ascending, symmetric (9% with asymmetry) 7% children with relapse 5 6 7 Transverse Myelitis 8 Polio virus Genus: Enterovirus Family: Picornaviridae Three major antigenic sites (surface proteins (VP13) Three serotypes (1, 2, and 3) What is Poliomyelitis? Polio= gray matter Myelitis= inflammation of the spinal cord This disease result in the destruction of motor neurons caused by the poliovirus. Infectivity Poliovirus has been isolated from stool more than two weeks before paralysis and 3-6 wks after the onset of paralysis Excretion in some patients may occur for up to 2 months Duration of Fecal Excretion of Wild Polioviruses Viral excretion drops significantly after 14 days, but poliovirus may still be detected up to 60 days after onset. Early Detection Late Detection POLIO 20 Reservoir Poliovirus infects only human beings and there is no animal reservoir. The virus does not survive long in the environment outside the human body. There is no long-term carrier state. Environment 1. Soil 2. Sewage 3.Surface water 13 Time for virus infectivity to fall by 90% Summer 1.5 days Winter 20 days At 23 o C 26 days At 2 o C 180 days Fresh 5.5 days Sea 2.5 days A child with no intestinal Immunity has free Receptors for WPV and help replicating Wild Poliovirus Receptors Wild Poliovirus Age group distribution for poliomyelitis % distribution of polio cases by age, Sudan (N) Jan-Nov 2004 50 45 40 35 30 % 25 20 15 10 5 0 1 years 2 years 3 years 4 years 5 years > 5 years DISTINGUISHING FEATURES OF POLIO 16 1. Asymmetric flaccid paralysis (usually affecting proximally) 2. Fever at onset (high, always present at onset, gone the following day) 3. Rapid progression of paralysis 4. Residual weakness after 60 days 5. Preservation of sensory nerve function The disease of poliomyelitis has a long history. The first example may even have been more than 3000 years ago. An Egyptian stele dating from the 18th Egyptian dynasty (1580 - 1350 BCE) shows a priest with a deformity of his leg characteristic of the flaccid paralysis typical of poliomyelitis. . Polio Eradication WHO strategies: -routine immunization -national immunization days -surveillance of acute flaccid paralysis -mopping up of immunization Global situation At the time of adoption of polio eradication target (1988) 350,000 polio cases every year 125 countries endemic for polio. In 2011 650 cases (i.e.> 99% reduction) Only 4 endemic countries (Nigeria, India, Pakistan & Afghanistan) 10 re-infected countries In 2012 222 cases (i.e.> 99.5% reduction) Only 3 endemic countries (Nigeria, Pakistan & Afghanistan). In 2013 up to date 2 cases from Pakistan Only 3 endemic countries (Nigeria, Pakistan & Afghanistan) Polio situation in Yemen 20 Last case of WPV in Yemen was in April 2006 from Ibb Governorate, Hubish district. Poliomyelitis in 1988 350 000 cases / 125 countries Wild Poliovirus 2011 Wild Poliovirus 2012 Polio – EMRO in 2012* Polio Cases *EMRO- Polio- Data as of 08 January 2013 2011 2012* Country P1 P3 P1 P3 Pakistan 190 2 58 0 Afghanistan 76 0 37 0 2011 Regional Risk Assessment Map* Risk Interpretation (Score) ( ≤50) High (51–74) Medium ( ≥75) Low Not Included Non EMR countries Eastern Mediterranean Region *Data through end of Q3 2011 AFP and Poliomyelitis EMR 2012 Polio: Last Cases Americas Peru 1991 Western Pacific Cambodia 1997 ? Europe Tajikistan 2010 Polio Eradication Rapid progression of paralysis, <2-3 days (from onset to maximum paralysis) Loss of muscle tone, “floppy” (as opposed to spastic or rigid) WEAKNESS, LOSS OF FUNCTION/MOTION 28 AFP- Case Definition • Any case of AFP in a child <15 years of age or • Any case of paralytic illness (regardless of age) in which a clinician suspects polio . Differential Diagnosis of AFP 1. Poliomyelitis 2. Gullian Barrie Syndrome 3. Transverse Myelitis 4. Traumatic Neuritis 5. Cerebral Malaria 6. Meningitis Complications 7. Hypokalaemia 9. Pott”s Disease 10. Diphtheria Stool Collection 2 Stool specimens 24-48 hrs. apart Within 14 days of onset of paralysis Can be done up to 2 months from onset At least 8 gm. Each Special container must be used Side of the container to be labeled with Name & EPID No. “Reverse Cold Chain”to be maintained 60th Day FU Examination Done on 60th day from onset Must be done < 70 days from onset Type of paralysis is verified (Flaccid or Spastic) Presence or absence of Residual weakness AFP SURVEILLANCE MESSAGE If the diagnosis has been settled, Why to notify about AFP case? Please, do not hesitate to notify about any AFP case whatever the diagnosis is. AFP case investigation does not interfere with your line of management for the case. Hot Cases AFP Cases with symptoms typical of polio Fever at onset, short progression, Asymmetric paralysis, sensation intact… and any of the following: Virological AFP Case Classification Scheme (non-polio AFP rate > 2/100.000, >= 80% with adequate specimens): confirm Wild poliovirus AFP case inadequate specimens No wild poliovirus residual weakness, died or lost to followup no residual weakness two adequate specimens expert review poliocompatible discard discard discard Onset of Paralysis < 7 days of onset Detection & notification The Process of AFP surveillance < 14 days of onset < 3 days of being sent Case investigation & specimen collection > 60 days of onset < 28 days of Primary culture receipt Specimens arrive at National laboratory results reported to EPI Isolates sent to regional lab Case classification (< 90 days of paralysis onset) Follow up examination results reported to EPI